| abstract |
FIELD: veterinary science. SUBSTANCE: vaccine contains suspension of viable spores of anthrax vaccine strain "55-VNIIVV&M" at initial concentration of 180- 360 mln. spores/cm 3 , cultural virus-containing raw material of cloned sheep variola virus of "NISKHI" strain at initial activity of not less than 5.0 Lg TCD 50/cm 3 and lactosopeptonic stabilizer. EFFECT: higher immunogenicity, areactogenicity, safety and stability of the given vaccine during storage period. 3 tbl, 3 ex |